Gut microbiome and retinal diseases: an updated review

Abstract

Purpose of reviewThe gut microbiome, trillions of microorganisms residing in our digestive tract, is now believed to play a significant role in retinal diseases. Breakthroughs in computational biology and specialized animal models have allowed researchers not only to characterize microbes associated with retinal diseases, but also to provide early insights into the function of the microbiome in relation to biological processes in the retinal microenvironment. This review aims to provide an update on recent advances in the current knowledge on the relationship between the gut microbiome and retinal disorders. Recent findingsRecent work demonstrates distinct gut microbial compositions associated with retinal diseases such as agerelated macular degeneration and retinopathy of prematurity. Currently, it is believed that gut dysbiosis leads to increased gut permeability, elevated circulation of bacterial products, microbial metabolites and inflammatory mediators that result in immune dysregulation at distant anatomic sites including the retina.

Composition of the gut microbiome, role of diet, lifestyle, and antioxidant therapies in diabetes mellitus and diabetic retinopathy

“…The association of dysbiosis with ocular disorders such as uveitis, age-related macular degeneration, and choroidal neovascularization have been established, however the connection between gut dysbiosis and DR is still being elucidated. 53,60 Previous studies have investigated the mechanisms connecting the gut microbiome to the retina in diabetic patients, known as the “microbiota-retina axis.” 61–64 This axis is believed to play an important role in retinal homeostasis and there is growing evidence that a diabetic-associated microbiome could lead to increased inflammation and vascular permeability, promoting the development of DR. 45 Moubayed et al found that Bacteroidetes were more abundant in the DR than in the DM and healthy control (HC) groups, suggesting that progression of retinal disease in T2DM may increase with higher composition of this phyla. 65 However, subsequent studies by Khan et al found that although the Bacteroidetes/Firmicutes (B/F) ratio was elevated in a univariate analysis, these results were not significant in a multivariate analysis when controlling for confounders such as age, gender, BMI, HbA1C, hypertension, cardiovascular disease, dyslipidemia, and diet.…”

Editorial: Introduction to Translational Research Section 2022

“…Traveling from the eye to the gut, our understanding of how bacteria in our body affect our health has exploded to the forefront of medicine. Nadeem et al [3] update us on how breakthroughs in computational biology along with specialized animal models have allowed researchers to characterize the influence of the gut microbiome on retinal diseases. In the future, this research may lead to novel therapies involving changing microbial composition to modulate retinal diseases.…”